山西肛泰肛肠医院在哪里山西痔疮便秘怎么办,山西哪里治男性痔疮,太原肛息肉,太原割痔疮哪个医院好,太原放屁出血什么原因,太原外痔需要动手术吗,太原产后脱肛怎么办

The election may be over but the term of President Donald Trump is not. So what can President Trump do between now and January 20, 2021?FIVE BIG AREASPresident Trump will likely be exploring options without Congress. The most obvious actions include the power to pardon, appoint top officials, fire top officials, approve military action and issue executive orders. President Trump could very well pardon anyone he wants, including former advisers Michael Flynn or Paul Manafort. President Trump may also explore the possibility of preemptively pardoning members of his own family as various investigations continue. HIRING AND FIRING President Trump has already begun the process of firing some top officials, including Secretary of Defense Mark Esper. President Trump may exercise that authority with other officials, such as the FBI Director who he has publicly criticized. The commander-in-chief may also continue to appoint top posts. He appears poised to confirm Judy Sheldon to the Federal Reserve before the end of his term, a position which has the power to influence interest rates and monetary policy for decades to come. EXECUTIVE ACTIONSPresident Trump will also continue to have authority to conduct military strikes since he is Commander-in-Chief. He will also have the ability to issue executive orders, although any order he issues could be immediately reversed when President-elect Biden takes office. 1428

The Food and Drug Administration on Wednesday authorized the first rapid coronavirus test that doesn’t need any special computer equipment to get results.The 15-minute test from Abbott Laboratories will sell for , giving it a competitive edge over similar tests that need to be popped into a small machine. The size of a credit card, the self-contained test is based on the same technology used to test for the flu, strep throat and other infections.It’s the latest cheaper, simpler test to hit the U.S. market, providing new options to expand testing as schools and businesses struggle to reopen and flu season approaches. The FDA also recently greenlighted a saliva test from Yale University that bypasses some of the supplies that have led to testing bottlenecks.Both tests have limitations and neither can be done at home. Several companies are developing rapid, at-home tests, but none have yet won approval. Abbott’s new test still requires a nasal swab by a health worker, like most older coronavirus tests. The Yale saliva test eliminates the need for a swab, but can only be run at high-grade laboratories.And in general, rapid tests like Abbott’s are less accurate than lab-developed tests. The FDA said in a statement announcing the decision that negative results with Abbott’s test may need to be confirmed with a lab test in some cases. The agency granted Abbott’s test an emergency use authorization late Wednesday for patients with suspected COVID-19.The two additions should help expand the number of available tests. The U.S. is now testing about 690,000 people per day, down from a peak of 850,000 daily tests late last month. Many public health experts believe the country will soon need to test vastly more people to find those who are infected, isolate them and contain the virus.The FDA noted that Abbott’s test could be used in a doctor’s office, emergency room or some schools. “Given the simple nature of this test, it is likely that these tests could be made broadly available,” the FDA said.Since the start of the pandemic, nasal swab tests that are sent to a lab have been the standard for COVID-19 screening. While considered highly accurate, the tests rely on expensive, specialized machines and chemicals. Shortages of those supplies have led to repeated delays in reporting results, especially during a spike in cases last month.Government and health experts view rapid tests that can be run outside the laboratory system as key to boosting capacity.“Those screening tests are what we need in schools, workplaces and nursing homes in order to catch asymptomatic spreaders,” said Dr. Jonathan Quick of the Rockefeller Foundation, in an interview earlier this month. The nonprofit group has called for the U.S. to conduct about 4 millions per day by October, mostly rapid, point-of-care tests.Abbott’s BinaxNOW is the fourth rapid test that detects COVID-19 antigens, proteins found on the surface of the coronavirus, rather than the virus itself. It’s considered a faster, though sometimes less precise, screening method. The other tests need to be inserted into a small machine.Inside the Abbott test is a specially coated strip that interacts with COVID-19 antigens. The patient’s nasal swab is inserted into the card and a few drops of a chemical solution are added. Markings appear on the card to indicate whether the sample is positive or negative — much like a pregnancy test.Two other makers of antigen tests — Quidel and Becton Dickinson have said they haven’t been able to meet demand for the tests. A third, LumiraDx, plans to begin shipping its recently approved antigen tests by the end of this month. Abbott expects to begin shipping tests in September, reaching 50 million tests a month in October.The influx of antigen tests will go a long way toward meeting the Trump administration’s projection that 90 million COVID-19 tests a month will be available by September if needed. But U.S. “testing czar” Adm. Brett Giroir has stressed that the U.S. can contain the outbreak with far fewer tests.“That’s the capacity ... we do not need that many tests to safely and sensibly reopen,” Giroir told reporters on a recent call. He pointed to several key indicators that have been falling, including new infections and hospitalizations, even as testing has slowed.Earlier this month, the FDA authorized Yale’s saliva-based test, which is expected to cut the time and cost compared with similar tests. It’s the fifth COVID-19 saliva tests OK’d by regulators. All require lab processing.Developed by Yale’s School of Public Health, SalivaDirect can use any sterile container to collect a sample, not the special tube needed with earlier tests, and requires less chemicals. Outside experts welcomed the new approach but noted its limitations.“It’s not a rapid test, it’s a laboratory-based test that will still be prone to the same massive delays as any other test,” said Dr. Michael Mina of Harvard University.___Follow Matthew Perrone on Twitter: @ AP_FDAwriter.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5201

The death toll from a powerful explosion in Beirut Tuesday has reached 100 and is still climbing. At least 4,000 others were injured.While no one knows yet exactly how many people died in the blast, the destruction was so extensive that the shockwave was felt across the city.The blast, which began as a fire in a port warehouse, happened just after 6 p.m. local time.Beirut's emergency services were so overwhelmed that it was up to whoever could help to provide comfort to the injured. Open lots were turned into field hospitals.In an instant, lives were lost and livelihoods were destroyed."The whole house collapsed on us," one woman who survived the blast said.Following the explosion, Michel Haibe visited the site of what used to be his electrical goods store."Forty years," Haibe said. "War, we've seen woes of every kind, but not like this. As if the economic crisis, coronavirus, the revolution weren't enough, this tops them all."Life was already a struggle in Lebanon with its economy in freefall and the coronavirus on the rise. Now, the country's capital must dig out of another tragedy."We got here an hour ago, and as you can see, it's completely and utterly destroyed," bar owner Hadi Shahlawi said. "We've been open since last October and we've been fighting every month with different circumstances — the economic situation. It's catastrophic; what's happening in Lebanon is a catastrophe." 1417

The E.W. Scripps Company, based in Cincinnati, Ohio announced it has added two television stations to its business, bringing its current total to 35 stations in 26 markets.The stations purchased are ABC affiliates KXXV/KRHD in Waco, Texas, and WTXL in Tallahassee, Florida. Both were owned by Raycom Media."These two stations are strategic additions to our portfolio," said Brian Lawlor, President, Local Media."We have been interested in expanding into Texas for some time as we believe Texas will play an important part in U.S. politics moving forward," Lawlor said of the KXXV/KRHD purchase.Scripps owns WFTS in Tampa, WFTX in Fort Myers and WPTV in West Palm Beach, making WTXL its fourth in the state."The addition of Tallahassee will allow us to better cover the state's politics as we expand our reach beyond 50 percent of Florida’s television households," Lawlor said in a memo to Scripps employees.The announcement follows Scripps’ news Aug. 15 that it has completed the sale of its 34 radio stations for .5 million.Scripps' stations are affiliated with all of the Big Four television networks: ABC, NBC, CBS and FOX. The purchase of the two new stations adds 130 employees to The E.W. Scripps Company and brings it to 17 ABC affiliates. 1277

The Centers for Disease Control and Prevention is coming to Stark County, Ohio to investigate the area’s startling rate of teen suicides, according to the Ohio Department of Health.Federal health experts will spend two weeks here to figure out why a dozen Stark County teenagers have died by suicide since the end of summer.The CDC visit comes at the request of local and state health officials. According to the Canton Repository: 449